AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2016
Mar 4, 2016
31949_dirs_2016-03-04_511d5095-99fa-4aed-b45d-37bd80ff8ee1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-03-03
Reporting Person: MYLOD ROBERT J JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-03 | Ordinary Shares | P | 20000 | $15.78 | Acquired | 20000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 148114 | Direct |
Footnotes
F1: These shares are held by Annox Capital LLC, over which Mr. Mylod possesses sole voting and investment power.
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3